MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 64 filers reported holding MARKER THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $6,837 | -24.0% | 25,712 | 0.0% | 0.00% | – |
Q3 2022 | $9,000 | +12.5% | 25,712 | 0.0% | 0.00% | – |
Q2 2022 | $8,000 | -27.3% | 25,712 | 0.0% | 0.00% | – |
Q1 2022 | $11,000 | -54.2% | 25,712 | 0.0% | 0.00% | – |
Q4 2021 | $24,000 | -44.2% | 25,712 | 0.0% | 0.00% | – |
Q3 2021 | $43,000 | -40.3% | 25,712 | 0.0% | 0.00% | – |
Q2 2021 | $72,000 | +24.1% | 25,712 | 0.0% | 0.00% | – |
Q1 2021 | $58,000 | +56.8% | 25,712 | 0.0% | 0.00% | – |
Q4 2020 | $37,000 | -5.1% | 25,712 | 0.0% | 0.00% | – |
Q3 2020 | $39,000 | -26.4% | 25,712 | 0.0% | 0.00% | – |
Q2 2020 | $53,000 | +8.2% | 25,712 | 0.0% | 0.00% | – |
Q1 2020 | $49,000 | -33.8% | 25,712 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $74,000 | -43.5% | 25,712 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $131,000 | -22.9% | 25,712 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $170,000 | +18.9% | 25,712 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $143,000 | – | 25,712 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 2,000,000 | $15,840,000 | 6.76% |
NEA Management Company, LLC | 5,000,000 | $39,600,000 | 2.77% |
APIS CAPITAL ADVISORS, LLC | 90,000 | $713,000 | 1.07% |
683 Capital Management, LLC | 560,000 | $4,435,000 | 0.40% |
Perceptive Advisors | 2,000,000 | $15,840,000 | 0.36% |
One68 Global Capital, LLC | 30,000 | $238,000 | 0.30% |
CAXTON CORP | 23,915 | $189,000 | 0.22% |
Riggs Asset Managment Co. Inc. | 46,019 | $364,000 | 0.20% |
MYDA Advisors LLC | 68,000 | $539,000 | 0.18% |
MYDA Advisors LLC | 68,100 | $539,000 | 0.18% |